143 related articles for article (PubMed ID: 35151227)
1. Prediction and validation of GUCA2B as the hub-gene in colorectal cancer based on co-expression network analysis: In-silico and in-vivo study.
Nomiri S; Hoshyar R; Chamani E; Rezaei Z; Salmani F; Larki P; Tavakoli T; Gholipour F; Tabrizi NJ; Derakhshani A; Santarpia M; Franchina T; Brunetti O; Silvestris N; Safarpour H
Biomed Pharmacother; 2022 Mar; 147():112691. PubMed ID: 35151227
[TBL] [Abstract][Full Text] [Related]
2. Identification of key gene modules and genes in colorectal cancer by co-expression analysis weighted gene co-expression network analysis.
Wang P; Zheng H; Zhang J; Wang Y; Liu P; Xuan X; Li Q; Du Y
Biosci Rep; 2020 Sep; 40(9):. PubMed ID: 32815531
[TBL] [Abstract][Full Text] [Related]
3. Identification of hub genes in colorectal cancer based on weighted gene co-expression network analysis and clinical data from The Cancer Genome Atlas.
Zhang Y; Luo J; Liu Z; Liu X; Ma Y; Zhang B; Chen Y; Li X; Feng Z; Yang N; Feng D; Wang L; Song X
Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34308980
[TBL] [Abstract][Full Text] [Related]
4. Weighted gene co-expression network analysis combined with machine learning validation to identify key hub biomarkers in colorectal cancer.
Guo C; Xie B; Liu Q
Funct Integr Genomics; 2022 Dec; 23(1):24. PubMed ID: 36576616
[TBL] [Abstract][Full Text] [Related]
5. Identification of key genes in colorectal cancer diagnosis by co-expression analysis weighted gene co-expression network analysis.
Mortezapour M; Tapak L; Bahreini F; Najafi R; Afshar S
Comput Biol Med; 2023 May; 157():106779. PubMed ID: 36931200
[TBL] [Abstract][Full Text] [Related]
6. Application of weighted gene co‑expression network analysis to explore the potential diagnostic biomarkers for colorectal cancer.
Qin L; Zeng J; Shi N; Chen L; Wang L
Mol Med Rep; 2020 Jun; 21(6):2533-2543. PubMed ID: 32323816
[TBL] [Abstract][Full Text] [Related]
7. Employing bioinformatics analysis to identify hub genes and microRNAs involved in colorectal cancer.
Ebadfardzadeh J; Kazemi M; Aghazadeh A; Rezaei M; Shirvaliloo M; Sheervalilou R
Med Oncol; 2021 Aug; 38(9):114. PubMed ID: 34390411
[TBL] [Abstract][Full Text] [Related]
8. Identifying the key genes and microRNAs in colorectal cancer liver metastasis by bioinformatics analysis and in vitro experiments.
Zhang T; Guo J; Gu J; Wang Z; Wang G; Li H; Wang J
Oncol Rep; 2019 Jan; 41(1):279-291. PubMed ID: 30542696
[TBL] [Abstract][Full Text] [Related]
9. Experimental validation of in silico analysis estimated the reverse effect of upregulated hsa-miR-106a-5p and hsa-miR-223-3p on SLC4A4 gene expression in Iranian patients with colorectal adenocarcinoma by RT-qPCR.
Ranjbaran J; Safarpour H; Nomiri S; Tavakoli T; Rezaei Z; Salmani F; Larki P; Chamani E
Cancer Med; 2023 Mar; 12(6):7005-7018. PubMed ID: 36468451
[TBL] [Abstract][Full Text] [Related]
10. Identification of four novel hub genes as monitoring biomarkers for colorectal cancer.
Luo D; Yang J; Liu J; Yong X; Wang Z
Hereditas; 2022 Jan; 159(1):11. PubMed ID: 35093172
[TBL] [Abstract][Full Text] [Related]
11. A co-regulatory network of
Hu JM; Liu PY; Chen YC; Lin WZ; Chou YC; Tsai WC; Chu CM; Wu CC; Chang YT
Am J Cancer Res; 2023; 13(11):5271-5288. PubMed ID: 38058807
[TBL] [Abstract][Full Text] [Related]
12. Identification of novel biomarkers affecting the metastasis of colorectal cancer through bioinformatics analysis and validation through qRT-PCR.
Lian W; Jin H; Cao J; Zhang X; Zhu T; Zhao S; Wu S; Zou K; Zhang X; Zhang M; Zheng X; Peng M
Cancer Cell Int; 2020; 20():105. PubMed ID: 32256214
[TBL] [Abstract][Full Text] [Related]
13. Identification Hub Genes in Colorectal Cancer by Integrating Weighted Gene Co-Expression Network Analysis and Clinical Validation
Yuan Y; Chen J; Wang J; Xu M; Zhang Y; Sun P; Liang L
Front Oncol; 2020; 10():638. PubMed ID: 32426282
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive analysis of diabetic nephropathy expression profile based on weighted gene co-expression network analysis algorithm.
Gholaminejad A; Fathalipour M; Roointan A
BMC Nephrol; 2021 Jul; 22(1):245. PubMed ID: 34215202
[TBL] [Abstract][Full Text] [Related]
15. Exploring molecular markers and drug candidates for colorectal cancer through comprehensive bioinformatics analysis.
Li G; Zhu J; Zhai L
Aging (Albany NY); 2023 Jul; 15(14):7038-7055. PubMed ID: 37466419
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of an RBP gene signature for prognosis prediction in colorectal cancer based on WGCNA.
Cao L; Duan L; Zhang R; Yang W; Yang N; Huang W; Chen X; Wang N; Niu L; Zhou W; Chen J; Li Y; Zhang Y; Liu J; Fan D; Liu H
Hereditas; 2023 Mar; 160(1):10. PubMed ID: 36895014
[TBL] [Abstract][Full Text] [Related]
17. Follistatin-Like 3 Correlates With Lymph Node Metastasis and Serves as a Biomarker of Extracellular Matrix Remodeling in Colorectal Cancer.
Yang C; Cao F; Huang S; Zheng Y
Front Immunol; 2021; 12():717505. PubMed ID: 34335633
[TBL] [Abstract][Full Text] [Related]
18. CLCA4 and MS4A12 as the significant gene biomarkers of primary colorectal cancer.
Han J; Zhang X; Liu Y; Jing L; Liu YB; Feng L
Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32797167
[TBL] [Abstract][Full Text] [Related]
19. A network-based predictive gene expression signature for recurrence risks in stage II colorectal cancer.
Yang WJ; Wang HB; Wang WD; Bai PY; Lu HX; Sun CH; Liu ZS; Guan DK; Yang GW; Zhang GL
Cancer Med; 2020 Jan; 9(1):179-193. PubMed ID: 31724326
[TBL] [Abstract][Full Text] [Related]
20. mRNA-miRNA bipartite network reconstruction to predict prognostic module biomarkers in colorectal cancer stage differentiation.
Motieghader H; Kouhsar M; Najafi A; Sadeghi B; Masoudi-Nejad A
Mol Biosyst; 2017 Sep; 13(10):2168-2180. PubMed ID: 28861579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
